You are here

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Breast Cancer
Sex
Female
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- histologically or cytologically confirmed diagnosis with evidence of either metastatic
disease (Stage IV) of locally recurrent disease not amenable to curative resection or
radiation therapy (Stage IIIB).

- Her-2negative breast cancer or unknown Her-2 status.

- at least 1 measurable lesion as defined by RECIST.

- ECOG status 0-1

- adequate bone marrow, hepatic and renal function.

- left ventricular ejection fraction of greater than or equal to 50%.

- willingness to discontinue hormonal therapy.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- any previous chemotherapy for advanced disease.

- prior exposure to taxanes as (neo) adjuvant treatment less than 12 months prior to
randomization.

- symptomatic brain metastases.

- prior anti-IGF-1R based investigational therapy.

- peripheral neuropathy greater than grade 2.

NCT00678626
Pfizer
Withdrawn
Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Advanced Breast Cancer, Metastatic Breast Cancer
NCT03280303
All Genders
18+
Years
Multiple Sites
Breast Cancer Metastatic
NCT01876251
Females
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now